ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 17 November to 23 November 2025

The 10 most important of the 131 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Public health and primary care · BMC Prim Care · 2025-11-17

Systematic review of 18 randomised trials (438,285 people with CVD) with meta-analyses: quality improvement interventions vs usual care improved lipid-lowering prescribing (OR 1.46) and reduced MACE (OR 0.84) and total mortality (OR 0.87) in primary care and hospitals.

Meta-analysisn = 438,285
Hafiz et al. Effectiveness of quality improvement interventions in improving cardiovascular disease-related outcomes in primary and tertiary care: A systematic review and meta-analyses
Women's health · Am J Obstet Gynecol · 2025-11-21

Systematic review of 43 observational studies (25 meta-analysed) in adult women: higher physical activity was associated with lower odds of urinary incontinence cross-sectionally (OR 0.70) and longitudinally (OR 0.82). Sedentary behaviour showed no significant association.

Meta-analysisn = 295,513
Sánchez-Martín et al. Association of physical activity and sedentary behavior with urinary incontinence in adult women: a systematic review and meta-analysis of observational studies
Infectious diseases · Int J Infect Dis · 2025-11-22

Systematic review of 181 studies (63,671 invasive pneumococcal disease cases, 20 Latin American and Caribbean countries) in high-risk groups: median incidence 13.13/100,000/year, case fatality 17% (35% in adults ≥60); non-vaccine serotypes rose after PCV introduction.

Meta-analysisn = 63,671 cases
Bardach et al. Burden and serotype distribution of invasive Pneumococcal disease among high-risk patients from Latin America and the Caribbean: A systematic review and meta-analysis
Psychiatry · Am J Psychiatry · 2025-11-19

Meta-analysis of 159 placebo-controlled comparisons (13,020 participants) of adjunctive treatments for negative symptoms of schizophrenia: effect sizes shrank with larger sample size (b=−0.60) and more sites (b=−0.33), mainly through greater placebo-arm improvement.

Meta-analysisn = 13,020
Kantrowitz et al. Effect Size Deflation With Increasing Sample Size in Adjunctive Trials for Negative Symptoms in Schizophrenia: A Meta-Analysis and Meta-Regression Across Mechanisms of Action

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.